CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 72 enrolled
Drug / intervention
Extracorporeal shockwave therapy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01600118
NCT01600118Phase 3Completed

Effect of Low-energy Extracorporeal Shock Waves on Periodontal and Endodontic Parameters

Medical University of Vienna·interventional·Posted May 16, 2012·Updated Oct 12, 2015

In Brief

A Phase 3 clinical trial evaluating Extracorporeal shockwave therapy and No extracorporeal shockwave for Tooth Stability and Blood Flow. Completed, enrolled 72 participants across 1 site.

Detailed Summary

This randomized clinical trial investigates the effect of the extracorporeal shockwave therapy (ESWT) on periodontal and endodontical parameters. The ESWT is a scientifically approved non invasive method to influence bone turnover and tissue regeneration. The hypotheses of this trial are that ESWT increases the periodontal stability of orthodontically aligned teeth as well as increase the blood flow. Increasing the periodontal stability would reduce the retention phase, relapse risk and accelerate the rehabilitation of the surrounding tissues.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustria
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 16, 2012
Enrollment StartSep 1, 2011
Primary CompletionOct 1, 2013
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.1 years ago

Interventions

Extracorporeal shockwave therapydevice

1000 impulses

No extracorporeal shockwavedevice

0 impulses, acoustic effect